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Abstract  
Introduction: Endotoxins, in the form of lipopolysaccharides (LPS), are potent 
inducers of biliary injury. However the mechanism by which injury develops remains 
unclear. We hypothesized that hepatic macrophages are pivotal in the development of 
endotoxin-induced biliary injury and that no injury would occur in their absence. 
Material and methods: Clodronate liposomes were used to deplete macrophages from 
the liver. Forty-eight rats were equally divided across six study groups: sham operation 
(sham), liposome treatment and sham operation (liposomes+sham), 1 mg/kg LPS i.p. 
(LPS), liposome treatment and LPS administration (liposomes+LPS), hepatic 
ischaemia-reperfusion injury with LPS administration (IRI+LPS) and liposome 
treatment followed by IRI+LPS (liposomes+IRI+LPS). Following six hours of 
reperfusion, blood, bile, and liver tissue was collected for further analysis. Small bile 
duct injury was assessed, serum liver tests were performed and bile composition was 
evaluated. The permeability of the blood-biliary barrier (BBB) was assessed using 
intravenously administered horseradish peroxidase (HRP).  
Results: The presence of hepatic macrophages was reduced by 90% in LPS and 
IRI+LPS groups pre-treated with clodronate liposomes (P <0.001). Severe small bile 
duct injury was not affected by macrophage depletion, and persisted in the 
liposomes+IRI+LPS group (50% of animals) and liposomes+LPS group (75% of 
animals). Likewise, BBB impairment persisted following macrophage depletion. LPS-
induced elevation of the chemokine Mcp-1 in bile was not affected by macrophage 
depletion.  
Conclusions: Depletion of hepatic macrophages did not prevent development of biliary 
injury following LPS or LPS-enhanced IRI. Cholangiocyte activation rather than 
macrophage activation may underlie this injury. 
 
Keywords: Macrophages, Cholangiocytes, Endotoxaemia, Donation after circulatory 
death, Liver transplantation  
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1. Introduction  
Ischaemic-type biliary stricture (ITBS) formation remains one of the most troublesome 
complications following liver transplantation using livers donated after circulatory death 
(DCD) (1, 2). During the DCD retrieval process, ischaemia of intra-abdominal organs 
such as the gut occurs, and this may result in the release of endotoxins in the portal 
circulation upon reperfusion (3). We previously showed that endotoxins, in the form of 
lipopolysaccharides (LPS), are potent inducers of biliary injury (4). Administration of 
LPS in a hepatic ischaemia-reperfusion injury (IRI) model resulted in a prompt and 
severe small bile duct injury, which was characterised by degenerative changes of 
cholangiocytes and ductular proliferation. The injury was associated with the 
development of the clinical features of cholestasis and increased leakage of 
macromolecules across the blood-biliary barrier (BBB) (4). In the present study, we 
further explored the mechanisms by which LPS induced biliary injury in this model by 
addressing the involvement of hepatic macrophages.  
Kupffer cells, the liver-resident macrophages, are activated by binding of LPS to Toll-
like receptor-4 (TLR-4) (5). Kupffer cell activation plays a pivotal role in the 
development of hepatic IRI (6). Upon activation by endogenous damage-associated 
and/or pathogen-associated molecular pattern (DAMP/PAMP) molecules, Kupffer cells 
produce reactive oxygen species and pro-inflammatory cytokines, which result in the 
recruitment of neutrophils and the development of tissue damage (7). Through enhanced 
Kupffer cell activation, endotoxemia can substantially aggravate IRI, as was observed 
during organ retrieval and liver transplantation (7-10).  Moreover, primary graft non-
function following DCD liver transplantation was associated with a higher degree of 
Kupffer cell activation (11). In animal models, IRI and endotoxin-aggravated IRI was 
ameliorated by depleting Kupffer cells, as evidenced by reduced hepatocellular damage 
and decreased recipient mortality (8, 12). It is currently unclear whether hepatic 
macrophages have a role in the development of endotoxin-induced biliary injury.  
The role of cholangiocytes in immune responses is increasingly recognised (13). They 
express various TLRs, and upon activation they release pro-inflammatory cytokines 
such as tumor necrosis factor-α (Tnf-α) and interleukin-6 (Il-6) in the bloodstream and 
biliary compartment (13, 14). Additionally, interferon-γ (IFNγ) and Tnf-α increase the 
expression of Tlr4 on cholangiocytes, augmenting their response to LPS in vitro (15). 
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Lastly, cholangiocytes can act as antigen-presenting cells as they express major 
histocompatibility complex II (MHC II) on their surface (16). Collectively, these data 
suggest that endotoxin-induced damage of the cholangiocyte might be a direct effect 
and/or might be mediated via a Kupffer cell response.  
The aim of the current study was to explore the role of hepatic macrophages in the 
development of biliary injury resulting from LPS administration in a hepatic IRI model. 
We hypothesised that in the absence of macrophages, the BBB would remain intact and 
biliary injury would be ameliorated.  
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2. Material and Methods 
2.1 Animals and experimental groups 
Male Sprague-Dawley rats (250g; Animal Recourses Centre, Perth, Australia) were 
used for this study. Procedures were in accordance with the Australian Code for the 
Care and Use of Animals for Scientific Purposes and approved by the Animal Ethics 
Committee of the University of Queensland. All animal experiments complied with 
ARRIVE guidelines. 
For the purpose of the study, forty-eight animals were equally divided over six study 
groups: (1) laparotomy without any additional intervention (sham); (2) administration of 
1 mg/kg LPS in the peritoneal cavity (LPS); (3) 30 minutes of liver ischaemia and 
simultaneous administration of LPS in the peritoneal cavity (IRI+LPS); (4) pre-
treatment with clodronate liposomes followed by laparotomy (liposomes+sham); (5) 
pre-treatment with clodronate liposomes followed by administration of LPS in the 
peritoneal cavity (liposomes+LPS) and (6) pre-treatment with clodronate liposomes 
followed by 30 minutes of liver ischaemia plus reperfusion and simultaneous 
administration of LPS in the peritoneal cavity (liposomes+IRI+LPS). Data from animals 
in groups 1, 2 and 3 (no liposome treatment) was taken from our earlier study (4). 
  
2.2 Macrophage depletion and surgical procedure 
Clodronate encapsulated in liposomes (5 mg clodronate per milliliter, 
www.clodronateliposomes.com, Amsterdam, the Netherlands) was used to deplete 
hepatic macrophages (17). Animals in groups 4, 5 and 6 were injected with clodronate 
liposomes (0.5 ml/100 grams body weight) in the tail vein 48 hours prior to surgical 
intervention. Treatment with control (PBS) liposomes was not conducted as this can 
result in saturation of the phagocytotic function of macrophages (18). 
Midline laparotomy was performed under general anaesthesia with isoflurane and the 
common bile duct, hepatic artery and portal vein of the left lateral and medial lobes 
were identified. A vascular clamp (BH030R, BBraun, Bethlehem, PA, USA) was then 
placed across these structures to induce ischaemia to approximately 70% of the liver 
(IRI groups). Simultaneously, vehicle (0.9% sterile saline) or 1 mg/kg LPS from 
Escherichia coli serotype 0111:B4 (L3012, Sigma-Aldrich, St. Louis, MO, USA; 1 
μg/μl in sterile saline) was administered in the peritoneal cavity. Following 30 minutes 
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of ischaemia, the clamp was removed and the animals were allowed to recover. The 
LPS was not rinsed from the abdomen prior to wound closure. 
Following six hours of reperfusion, re-laparotomy was performed and a cannula was 
inserted in the common bile duct to allow for bile collection. Following the 
establishment of a steady bile flow, three bile samples were collected over 10-minute 
intervals. Animals were subsequently euthanised by exsanguination, and liver tissue 
from the left lateral and median lobes (subjected to ischaemia in the IRI groups) was 
collected for RNA extraction and histological evaluation.  
 
2.3 Immunohistochemical staining  
Formaldehyde-fixed paraffin-embedded liver sections of 4 µm thickness were stained 
with a monoclonal antibody against CD68 and CD163 (ED-1 and ED-2, resp., Serotec, 
Oxford, UK) to visualise the presence of mature macrophages including Kupffer cells 
(CD68
+ 
CD163
+
) as well as their non-phagocytotic precursors (CD68
+ 
CD163
-
). A 
monoclonal antibody against Ki67 (#M7248, Dako, Santa Clara, CA, USA) was used to 
assess proliferation. A TUNEL assay was used to detect DNA fragmentation in 
apoptotic cells according to the manufacturer’s instruction (TUNEL, #S7100, Merck 
Millipore, Billerica, MA, USA). The average number of CD 163, CD68, Ki67 and 
TUNEL positive cells per field was counted in five random, non-overlapping fields at 
200x magnification using ImageJ image analysis software (19). The number of Ki67 
and TUNEL positive biliary epithelial cells per field was expressed as percentage of 
total biliary epithelial cells. 
 
2.4 Serum and bile analysis 
Serum alanine transaminase (ALT), aspartate transaminase (AST), γ-glutamyl 
transferase (GGT), alkaline phosphatase (ALP), and bilirubin, as well as lactate 
dehydrogenase (LDH) in bile, were assayed using commercially available kits (Bioo 
Scientific Corporation, Austin, TX, USA). Total bile salt concentration in serum, as 
well as bile salty and phospholipid concentration in bile were measured in the first 
collected bile fraction using an enzymatic assay according to the manufacturer’s 
instructions (#80460, Crystal Chem, Inc., Chicago, IL, USA and #433-36201, Wako, 
Osaka, Japan).  
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2.5 Blood-biliary-barrier integrity assessment 
Horseradish peroxidase (HRP, Peroxidase from horseradish type II, P8250, Sigma-
Aldrich, St. Louis, MO, USA) was used to assess the permeability of the BBB in vivo as 
previously described (20). Two hundred microliter of HRP (5000 IU/mL in sterile 
water) was injected into the inferior vena cava of each animal 30 minutes after 
cannulation of the common bile duct. Bile was subsequently collected for 10 minutes to 
assess paracellular transport across tight junctions (21). A commercially available kit 
(#A22188, Thermo Fisher Scientific, Waltham, MA, USA) was used to determine 
activity of HRP in bile.  
 
2.6 RNA extraction and real-time polymerase chain reaction  
Total RNA was extracted from liver tissue using Trisure (Bioline, Taunton, MA) and 
cDNA was synthesised using a kit (SensiFAST, Bioline, Taunton, MA, USA). Real-
time quantitative polymerase chain reaction (RT-qPCR) was performed on a Viia7 
Real-time PCR system (Invitrogen, Carlsbad, CA, USA) using Sybr Green chemistry 
(Bioline, Taunton, MA, USA). Normalisation was performed using the geometric mean 
of glyceraldehyde phosphate dehydrogenase, β2-microglobulin and basic transcription 
factor 3 mRNA expression. The primer nucleotide sequences can be found in 
Supplementary Table 1.  
 
2.7 Western blot 
Thirty microgram total liver protein was heat-denatured and separated on a 10% SDS-
PAGE gel. Proteins were transferred onto polyvinylidene fluoride (PVDF) membranes 
(Biorad, Hercules, USA). Blocking was performed in TBS containing 0.1% Tween-20 
and 5% skimmed milk powder. Membranes were probed with primary antibodies 
against Claudin-1 (519000, Invitrogen, Carlsbad, CA, USA) and Gapdh (MAB376, 
Merck Millipore, Billerica, MA, USA). Secondary detection consisted of HRP-
conjugated goat anti-mouse IgG and goat anti-rabbit IgG antibodies (656120, 
Invitrogen, Carlsbad, CA, USA), respectively. Immunoreactive bands were visualized 
using a Supersignal West Femto chemiluminescent kit (Thermo Fisher Scientific, 
Waltham, USA) on an ImageQuant LAS 500 machine (GE Healthcare Life Sciences). 
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2.8 Histological evaluation 
Paraffin-embedded liver sections, stained with hematoxylin and eosin, were used for the 
semi-quantitative assessment of small bile duct injury. Depending on the size of the 
ducts (22), a small bile duct injury severity score (SBDISS) was used as previously 
described by Cheng et al (23). The score was based on bile duct damage (adapted from 
the Banff criteria for acute rejection) and ductular proliferation, each of which scored 
from 0 (absent) to 3 (severe). An expert liver pathologist (CC) who was blinded to study 
group allocation performed the histological scoring. Endotoxins did not induce injury of 
the large bile ducts following six hours of exposure (data not shown). 
 
2.9 Cytokine array on bile samples 
Biliary concentrations of cytokines were measured to gain insight into the local 
inflammatory milieu surrounding cholangiocytes. Levels of intercellular adhesion 
molecule-1 (Icam-1), monocyte chemoattractant protein-1 (Mcp-1), tissue inhibitor 
metalloproteinase-1 (Timp-1), Il-6, interleukin–10 (Il-10) and L-selectin were 
determined using a multiplex ELISA array (QAR-CYT-2, RayBiotech, Norcross, GA, 
USA). Diluted samples of bile from the first 10-minutes collection interval were 
analysed according to the manufacturer’s instructions.  Fluorescence intensity was 
determined and data analysis was performed using the Q-analyser (RayBiotech, 
Norcross, GA, USA).  
 
2.10 Statistical analysis 
GraphPad Prism 7 software (GraphPad, San Diego, CA, USA) was used for statistical 
analysis. Continuous variables are reported as median [interquartile range] and graphed 
using box plots. A Kruskal-Wallis test was performed to compare all experimental 
groups. In the case of a significant outcome this was followed by three pre-defined post-
hoc comparisons with Dunn’s correction for multiple comparisons to evaluate the effect 
of macrophage depletion: sham versus liposomes+sham, LPS versus liposomes+LPS 
and IRI+LPS versus liposomes+IRI+LPS. Categorical variables are reported as 
frequencies (%) and represented in tabular form. A Fisher’s exact test was performed to 
compare categorical data. Eight animals were studied per group unless stated otherwise 
and a P-value <0.05 was considered statistically significant.  
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The isolated or combined effects of LPS/IRI in our animal model were previously 
reported (4). No formal statistical evaluation of these effects (in the groups that was not 
pretreated with liposomes) was made in the current study. 
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3. Results 
3.1 Effective depletion of mature macrophages from the liver 
Effectiveness of clodronate to deplete mature macrophages, including Kupffer cells, 
from the liver was studied by CD163 immunohistochemistry (Figure 1). In the sham 
group there were 105 [90–128] CD163+ cells per field. In the LPS and IRI+LPS groups 
this amounted to 157 [143–176] and 145 [130–170] per field. Following liposome 
pretreatment, the number of positive cells per field decreased in all groups to 17 (16%) 
(P =0.01), 16 (10%) (P <0.001) and 13 (11%) (P <0.001) positive cells per field, 
respectively. In addition, the number of CD68 positive cells per field was halved 
following liposome pre-treatment (Suppl. Figure 1). Thus, clodronate liposomes 
effectively reduced the numbers of mature macrophage in the liver. 
 
3.2 Macrophage depletion causes elevated liver function tests 
Serum ALT activity was not affected by hepatic macrophage depletion (Figure 2A). 
However AST was significantly increased in the macrophage-depleted groups compared 
to their non-depleted controls (sham: P=0.001, LPS: P=0.03 and IRI+LPS P=0.003, 
Figure 2B). LPS-induced hyperbilirubinemia, as noted in our previous study (4), was 
ameliorated upon depletion of macrophages (Figure 2C). On a transcriptional level, the 
expression of ATP-binding cassette protein Mrp2, which facilitates the biliary secretion 
of glucuronidated bilirubin, remained unaltered in the macrophage-depleted LPS and 
IRI+LPS groups (Suppl. Figure 2A). Following macrophage depletion, the previously 
noted serum elevation of bile salts tended to improve in the LPS group (P=0.06) but 
remained elevated in the IRI+LPS group (Figure 2D). This occurred despite unaltered 
expression of Na
+
-taurocholate co-transporting polypeptide (Ntcp), the transporter 
responsible for basolateral uptake of conjugated bile salts, in all groups ( Suppl. Figure 
2B). Cholestatic injury markers ALP and GGT were both significantly increased 
following macrophage depletion in the LPS-treated groups (Figure 2E,F). 
 
3.3 Macrophage depletion does not ameliorate small bile duct injury 
A small bile duct injury severity score (SBDISS) was calculated. Representative portal 
tract images are depicted in Figure 3A. None of the animals developed small bile duct 
injury in the group undergoing sham surgery. In line with our earlier observations, LPS 
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administration induced severe small bile duct injury (SBDISS>4) in 5 out of 8 (62.5%) 
animals, and this persisted in 6 out of 8 (75%) animals receiving liposome pre-
treatment. In the IRI+LPS group, severe small bile duct injury occurred in 5 out of 8 
(62.5%) animals, and this persisted after macrophage depletion (SBDISS>4 in 4 out of 8 
animals).  
Macrophage depletion did not affect LPS-induced elevation of LDH activity in bile, a 
biomarker for biliary injury (Figure 3B) (24). Biliary LDH activity tended to be 
increased in the liposomes+sham group compared to sham controls (P=0.09). 
 
3.4 Macrophage depletion prevents LPS-induced hepatocellular apoptosis and 
induces hepatocyte proliferation.  
To further characterize the cellular injury inflicted by LPS, we studied hepatocellular 
apoptosis and proliferation. Although hepatocytes are typically quiescent, parenchymal 
injury may trigger cell cycle re-entry to replace lost hepatocytes. Likewise, biliary 
injury may trigger a proliferative response (ductular reaction).  
On average, less than 10% of biliary epithelial cells were positive for Ki67, and this 
proportion was not affected by macrophage depletion. However, the total number of 
Ki67
+
 cells per field, primarily representing hepatocytes, was significantly increased in 
all macrophage-depleted groups (sham: +2.6 fold, LPS: +1.9 fold, IRI+LPS: +1.8 fold, 
P < 0.001 for all groups) (Figure 4A,B).  
Macrophage depletion did not induce apoptosis of biliary epithelial cells. Endotoxins 
however did induce hepatocellular apoptosis in the LPS and IRI+LPS groups (P<0.001) 
(Figure 4C,D), and this could be prevented by macrophage depletion (LPS: 7 fold 
reduction of TUNEL
+
 cells, IRI+ LPS: 3 fold reduction of TUNEL
+
 cells, P < 0.001). 
Necrosis or influx of neutrophils was not observed in any of the groups, and there were 
no signs of activation of endothelial cells (data not shown). 
 
3.5 Persistent impairment of the BBB following macrophage depletion 
In the sham group, macrophage depletion led to a significant increase in the output of 
intravenously administered HRP in bile suggesting increased BBB permeability (Figure 
5A). Elevated biliary HRP activity after LPS administration was not improved by 
macrophage depletion in either group. We subsequently assessed gene expression levels 
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of the tight junction protein Claudin-1 (figure 5B). Reduced Claudin-1 expression in the 
LPS-only group remained low following liposome pre-treatment, but was significantly 
increased by macrophage depletion in the IRI+LPS group. Nonetheless, the expression 
did not exceed that of the untreated sham controls (-1.4 fold Sham, P=0.19). LPS 
treatment or macrophage depletion did not alter Claudin-1 protein levels (Figure 5C,D). 
 
3.6 Macrophage depletion increased bile flow and total bile salt secretion 
Bile flow was increased following macrophage depletion, reaching significance in the 
LPS group. Additionally, bile salt output was increased in both LPS-treated groups 
following macrophage depletion, while phospholipid output was increased only in the 
LPS+IRI group (Figure 6A-C). This was accompanied by increased expression of the 
bile salt export pump (Bsep) in the LPS group (Figure 6D). Expression of Mdr2, 
encoding the flippase that facilitates canalicular secretion of phospholipids, remained 
unaltered in both LPS-treated groups (Figure 6E).  
 
3.7 Biliary cytokine and chemokine levels following macrophage depletion 
The biliary concentration of several cytokines and chemokines previously reported to be 
produced by cholangiocytes were measured to determine the effect of macrophage 
depletion on the local inflammatory milieu surrounding cholangiocytes (Figure 7 and 
Supplementary Figure 3). Absolute level of Il-6 was low relative to other factors 
examined, and was not affected by macrophage depletion in the LPS and IRI+LPS 
groups (Figure 7A). Clodronate liposome treatment increased biliary Icam-1 protein in 
the LPS+IRI group to control levels (Figure 7B). Elevation of Mcp-1 in bile in the LPS 
groups was not affected by macrophage depletion (Figure 7C). LPS-induced elevated 
Timp-1 levels, as noted in our previous study (4), were further increased upon 
macrophage depletion in the IRI+LPS group (Figure 7D). Il-10 and L-selectin levels 
were not affected by LPS administration or LPS-aggravated IRI, but concentrations of 
these proteins in bile increased upon macrophage depletion (Figure 7E and F). 
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4. Discussion 
In the current study, clodronate liposomes were used to deplete hepatic macrophages 
from the liver. The development of biliary injury, resulting from exposure to LPS or 
LPS-aggravated IRI, occurred independently of the presence of hepatic macrophages 
and impairment of the BBB persisted despite effective depletion of hepatic 
macrophages. To our knowledge, this is the first study to explore the role of hepatic 
macrophages in the development of LPS-induced biliary injury.  
In this study, cells positive for CD163, a marker of mature macrophages, were largely 
depleted from the liver following treatment with liposomes. Clodronate liposomes have 
previously been shown to be highly effective in depleting the mature macrophage 
population from the liver (25-27). Following intravenous injection, phagocytic cells 
including Kupffer cells take up the liposomes and apoptosis is induced once toxic 
intracellular levels of clodronate have been reached (18).  
In the current study, serum elevations of AST, ALP and GGT were observed following 
clodronate liposome treatment. These findings differ from those previously reported. 
Macrophage depletion from donor livers using gadolinium chloride was found to be 
beneficial for early graft function and increased survival in animal studies (12). It 
furthermore reduced hepatic LPS toxicity and endotoxin-aggravated IRI (8, 28). A 
possible explanation for the increased serum liver enzymes in the present study could be 
impaired clearance of these enzymes, a role recently attributed to Kupffer cells (25). 
This was further supported by absence of histological evidence of hepatocellular injury 
in the liposomes+sham group (data not shown).  
LPS-induced hepatocellular apoptosis was ameliorated by macrophage depletion in the 
current experiment. This may be explained by reduced macrophage production of Tnf-α, 
an activator of the intrinsic pathway of apoptosis (29). In support of this notion, Tnf-α 
gene expression was found to be reduced in the macrophage-depleted groups (data not 
shown) 
An explanation for the increase in the number of proliferating hepatocytes following 
macrophage depletion could be the release of cell cycle re-entry promoting factors in 
apoptotic macrophage remnants. In the setting of partial hepatectomy, priming factors 
released by activated macrophages are known to play an important role in initiating the 
process of liver regeneration (30).  
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Despite strong evidence that hepatic macrophages play an important role in the 
development of hepatic IRI and endotoxin-aggravated hepatic IRI, we did not observe 
improvement in biliary injury following macrophage depletion. As cholangiocytes can 
produce cytokines and chemokines in response to LPS exposure, we hypothesised that 
cholangiocytes could play an import role in the development of biliary injury (13). The 
LPS-induced elevation of biliary Mcp-1 and Timp-1 protein levels, as observed in our 
previous study, persisted in the macrophage depleted LPS-groups highlighting the 
minor role of macrophages in their production. In addition, macrophage depletion had 
only a small effect on the levels of other cytokines measured in this study. The cellular 
source of these biliary cytokines is unclear, however cholangiocyte cytokine production 
may contribute to endotoxin-induced biliary injury. In fact, TLR-4 signalling and 
subsequent production of cytokines by cholangiocytes has been implicated in the 
pathophysiology of biliary diseases such as primary sclerosing cholangitis (13). It needs 
to be noted however that hepatic production of biliary cytokines could not be excluded 
in this study. 
Another explanation for the development of biliary injury upon depletion of hepatic 
macrophages could be a direct toxic effect of LPS on cholangiocytes. Cells from the 
reticulo-endothelial system together with hepatocytes are responsible for clearance of 
agents such as LPS from the portal circulation, and result in secretion of LPS in bile 
(26, 27, 31). An accumulation of endotoxins has been observed in cholangiocytes of 
patients with primary biliary cholangitis and primary sclerosing cholangitis (32). 
Previous studies have shown that endotoxin clearance and secretion into bile can occur 
in the absence of macrophages, as hepatocytes are able to take up LPS and release it in 
the biliary space (12, 33). As cholangiocytes would remain exposed to LPS, this could 
explain why biliary injury developed in the macrophage-depleted groups.  
The impairment of the BBB following exposure to LPS persisted upon depletion of 
macrophages. Macrophages, by clearing endogenous endotoxins, may play a role in 
maintaining the BBB as increased levels of HRP appeared in bile in the 
liposomes+sham group. Tight junctions are the main structural components of the BBB, 
and its permeability can be tested using macromolecules (e.g. HRP) that cross the BBB 
from the blood stream via the paracellular route (21). Endotoxins as well as individual 
(pro-inflammatory) cytokines such as Tnf-α, Il-6 and INFγ have previously been found 
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to impair BBB function (34-36). Even though serum cytokine concentrations are likely 
reduced following macrophage depletion, the production of cytokines in bile was 
maintained, which could have affected the BBB function. Alternatively, the increased 
concentration of HRP in bile observed in the liposomes+sham group could also be the 
result of reduced phagocytosis of HRP due to the depletion of macrophages. Persistent 
dysfunction of the BBB could lead to leakage of toxic bile in the surrounding tissues 
resulting in cellular damage (37). Furthermore, barrier impairment could lead to leakage 
of bile salts from the canaliculi into the blood stream resulting in increased serum bile 
salt concentrations as seen in this study.  
A limitation of the study is the short duration of the injury, and the fact that 
cholangiocytes were not separated from other liver cell types for analyses. 
Cholangiocytes represent a small proportion of the total hepatic cell population, and 
total hepatic mRNA will in general provide little information on transcriptional changes 
in cholangiocytes. Furthermore, this study only assessed the short-term effects of LPS 
administration or IRI, and further work is required to determine if biliary strictures 
would develop over time. The CD14/TLR4 signalling pathway has previously been 
linked to the development of ITBS following liver transplantation (38). In addition, in a 
patient cohort study, immunological factors were associated with stricture formation in 
the periphery of the liver, affecting smaller bile ducts as was observed in this study (39, 
40).  
In conclusion, hepatic macrophage depletion did not prevent the development of biliary 
injury following LPS or LPS-aggravated IRI. Cholangiocytes can produce cytokines in 
a TLR4- dependent fashion, and results from this study suggest that these cells rather 
than hepatic macrophages play an important role in LPS-induced biliary injury. Studies 
using inhibitors of TLR4 or TNF-α signalling, to prevent LPS-induced biliary injury, 
could provide additional information on the aetiology of LPS-induced biliary injury.  
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7. Figure Legends 
 
Figure 1 Successful depletion of mature macrophages following clodronate liposome  
treatment. Groups of rats were pre-treated for 48 hours with clodronate 
liposomes and compared to animals that did not receive liposomes. Pre-
treatment was followed by sham operation, administration of 
lipopolysaccharides (LPS), or a combination of LPS and 30 minutes warm 
hepatic ischaemia (IRI+LPS). Animals were sacrificed after 6 hours of 
reperfusion. A) Representative light microscopy images of liver sections (200x 
magnification) stained for CD163 of animals pretreated with liposomes (bottom 
row) and those receiving no pretreatment (top row). B) Quantification of 
CD163
+
 cells per high-powered field. Data is graphed using box plots 
presenting median, minimum and maximum values. Statistical significance was 
evaluated using a Kruskal-Wallis test, and -if appropriate- three predefined 
post-hoc comparisons (sham versus liposomes+ sham, LPS versus 
liposomes+LPS and IRI+LPS versus liposomes+IRI+LPS). ** P < 0.01, ****P 
< 0.0001. 
 
Figure 2  Serum liver tests. Groups of rats were pre-treated for 48 hours with clodronate 
liposomes and compared to animals that did not receive liposomes. Pre-
treatment was followed by sham operation, administration of 
lipopolysaccharides (LPS), or a combination of LPS and 30 minutes warm 
hepatic ischaemia (IRI+LPS). Animals were sacrificed after 6 hours of 
reperfusion and serum activity or level of A) alanine transaminase (ALT, U/L), 
B) aspartate transaminase (AST, U/L), C) bilirubin (mg/dL), D) total bile salts 
(µmol/L), E) alkaline phosphatase (U/L) and γ-glutamyl transferase (U/L) was 
determined. * P < 0.05, **P < 0.01. 
 
Figure 3  Macrophage depletion does not ameliorate LPS-induced biliary injury. A) 
Representative light microscopy images of portal tracts (magnification 200x) 
with arrows indicating bile ducts, PV: portal vein, # hepatic artery. B) Activity 
of lactate dehydrogenase (LDH) in bile as a biomarker of biliary injury.  
 
Figure 4: Macrophage depletion prevents LPS-induced hepatocellular apoptosis and 
induces hepatocyte proliferation. Macrophage depletion reduces 
hepatocellular apoptosis and induces hepatocyte cell cycle re-entry. 
Representative light microscopy images of liver sections (200x magnification) 
stained for Ki67 (A) and TUNEL DNA fragmentation (TUNEL assay) (C) of 
animals pretreated with liposomes (bottom row) and those receiving no 
pretreatment (top row). Quantification of Ki67+ (B) and TUNEL+ cells (D) per 
high-powered field. Data is graphed using box plots presenting median, 
minimum and maximum values. Statistical significance was evaluated using a 
Kruskal-Wallis test, and -if appropriate- three predefined post-hoc comparisons 
(sham versus liposomes+ sham, LPS versus liposomes+LPS and IRI+LPS 
versus liposomes+IRI+LPS). ****P < 0.0001. 
 
Figure 5  Persistent impairment of the blood biliary barrier following depletion of  
macrophages. A) Activity of Horseradish peroxidase (HRP) leaking into bile 
following intravenous injection of 1000 IU HRP. B) Hepatic mRNA expression 
of Claudin-1 as assessed using RT-qPCR C) hepatic Claudin-1 protein 
quantification, D) Claudin-1 Western blot. * P < 0.05 
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Figure 6 Bile flow, bile composition and gene expression of canalicular transporters. 
A) Bile flow (μL/min), B) Total bile salt (µmol/10 min) and C) phospholipid 
(µg/ 10 min) output in bile during the first 10-minute collection period D) 
Hepatic mRNA expression of Bsep and E) Mdr2 determined by RT-qPCR.  * P 
< 0.05, **P < 0.01, ***P < 0.001. 
 
 
Figure 7 Cytokine and chemokine concentrations in bile. Biliary concentrations  
(ng/ml) of Il-6 (A),  Icam-1 (B), Mcp-1 (C) and Timp-1 (D), Il-10 (E) and L-
selectin (F). * P < 0.05, **P < 0.01.  
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Fig. 2 
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Fig. 3 
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Fig. 4 
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Fig. 5 
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Fig. 6 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 28 
 
Fig. 7 
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Highlights 
 
 Endotoxins, in the form of lipopolysaccharides, are potent inducers of biliary injury 
 Clodronate liposomes were used to deplete mature macrophages from the liver 
 Macrophage depletion did not amend the degree of endotoxin-induced biliary injury 
 Cholangiocyte activation rather than macrophage activation may underlie this injury 
